Recon: MHRA AI Airlock candidates selected; Gilead tests yearly anti-HIV shot

• Pfizer’s blockbuster Ibrance slows tumor progression in another type of breast cancer (STAT)
• I used to do health insurance company PR. Here’s what I think the backlash is missing (STAT)
• Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815M in 2023, report finds (STAT)
• Gilead to test once-a-year HIV prevention shot (STAT)
• US FDA identifies cases of liver injury after treatment with Intercept's drug (Reuters)
• Public-Private Partnerships Praised Amid Criticism of COVID-19 Response (MedTech Insight)
• After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale (Fierce Pharma)

• Europe allows Novo to include reduction of kidney disease in Ozempic label (Reuters)
• First victims of UK blood scandal offered compensation (Reuters)
• Lonza seeks deals as it exits health and ingredients to focus on contract development (Reuters)
• Five AI Technologies Selected For UK MHRA’s AI Airlock Pilot (MedTech Insight)
• UK Medtechs Fear Government Tax Rise Will Push Them Over The Edge (MedTech Insight)

• Arcellx won the battle of BCMA CAR-T therapies (STAT)
• What I’ve learned — the hard way — about AI in bio (STAT)
• Why Stoke Therapeutics’ Dravet syndrome drug is worth watching (STAT)
• Keros shares plunge as safety doubts prompt dosing pause in blood pressure drug trial (Reuters)
• Elevation to pay up to $368M in ADC deal; Bavarian Nordic closes San Diego site (Endpoints)
• Eli Lilly and Ro’s unlikely relationship (Endpoints)
• Pleno raises $25M for multiomics testing, names new CEO (Endpoints)
• CRO Ora showcases key role music plays in the blind community (Fierce Pharma)

• Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future (Endpoints)
• Labcorp closes takeover of Ballad Health outreach laboratory services (MedTech Dive)
• Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor (MedTech Dive)
• Masimo lays off 75 employees in California (MedTech Dive)
• Artivion says cybersecurity incident has disrupted order, shipping processes (MedTech Dive)
• Penetration Testing Strengthens Medical Device Security Against Emerging Threats (MedTech Insight)
• Thermo Fisher’s Allergen Farm: The ‘Secret Sauce’ Driving Its Diagnostic Progress (MedTech Insight)
• Deloitte 2025 Life Sciences Outlook Report Finds Medtech Leaders Focus On AI, GenAI Adoption Across Value Chain To Increase Efficiencies, Cut Costs (MedTech Insight)

• In a threat to patient trust, Texas hospitals must ask ‘Are you a U.S. citizen?’ (STAT)
• Health insurer Centene forecasts upbeat 2025 profit amid cost pressures (Reuters)
• Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisition (Endpoints)
• After a Hiatus, the BLOCKING Act is Back! (FDA Law Blog)